Search

Displaying results 5141 - 5150 of 7452 in total
  1. Drug

    Disitamab vedotin

    go.drugbank.com/drugs/DB17208
    Investigational

    It is currently being investigated for cancers.[A254721]

  2. Drug

    MGN-4893

    go.drugbank.com/drugs/DB17338
    Experimental

    In February 2011, it was granted FDA orphan designation for the treatment of polycythemia vera.[L47356]

  3. Drug

    Ixmyelocel-T

    go.drugbank.com/drugs/DB17601
    Investigational

    Developed by Vericel Corporation, it is being investigated for cardiomyopathy.

  4. Drug

    Dexamethasone palmitate

    go.drugbank.com/drugs/DB19168
    Investigational

    Dexamethasone palmitate is under investigation in clinical trial NCT05693467 (Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery).

  5. Drug

    Ridinilazole

    go.drugbank.com/drugs/DB15308
    Investigational

    Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)).

  6. Drug

    Hexobarbital

    go.drugbank.com/drugs/DB01355
    Experimental

    A barbiturate that is effective as a hypnotic and sedative.

  7. Drug

    anti-alpha5Beta1-integrin antibody

    go.drugbank.com/drugs/DB05870
    Experimental

    Integrins are important adhesion molecules that regulate tumor and endothelial cell survival, proliferation and migration. The integrin alpha5beta1 has been shown to play a critical role during angiogenesis. anti-alpha5beta1 integrin ant...

  8. Drug

    ICG-136

    go.drugbank.com/drugs/DB17343
    Experimental

    It was investigated for the treatment of acute myeloid leukemia.

  9. Drug

    Mozafancogene autotemcel

    go.drugbank.com/drugs/DB17723
    Investigational

    RP-L102 is a lentiviral vector carrying the Fanconi Anemia-A (FANCA) gene currently being developed by Rocket Pharmaceuticals for the treatment of Fanconi anemia type A

  10. Drug

    Etaracizumab

    go.drugbank.com/drugs/DB12213
    Investigational

    Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.